Updates are available Correction dated 2023-06-12
Click to view Correction: https://doi.org/10.1007/s12072-023-10555-4
-
Authors
Murakami, Serami
Imamura, Michio http://orcid.org/0000-0002-0745-991X
Uchida, Takuro
Suehiro, Yosuke
Namba, Maiko
Fujii, Yasutoshi
Uchikawa, Shinsuke
Teraoka, Yuji
Fujino, Hatsue
Ono, Atsushi
Nakahara, Takashi
Murakami, Eisuke
Okamoto, Wataru
Yamauchi, Masami
Kawaoka, Tomokazu
Miki, Daiki
Hayes, Nelson C.
Tsuge, Masataka
Aikata, Hiroshi
Ohira, Masahiro
Ohdan, Hideki
Oka, Shiro
- License Information
-
More Information
Article History
Received: 18 November 2022
Accepted: 1 April 2023
First Online: 26 April 2023
Change Date: 12 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12072-023-10555-4
Declarations
:
: Michio Imamura has received research funding from AbbVie. Hiroshi Aikata has received honoraria from Eisai Co., Ltd. and Chugai Pharmaceutical Co., Ltd. Serami Murakami, Takuro Uchida, Yosuke Suehiro, Maiko Namba, Yasutoshi Fujii, Shinsuke Uchikawa, Yuji Teraoka, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Wataru Okamoto, Masami Yamauchi, Tomokazu Kawaoka, Daiki Miki, Nelson C. Hayes, Masataka Tsuge, Masahiro Ohira, Hideki Ohdan and Shiro Oka declares that have no conflict of interest.
: Informed consent was obtained from all patients for being included in the study. The protocol for this research project has been approved by a suitably constituted Ethics Committee of the institution (Committee of Hiroshima University Hospital, Approval No. E-2405) and conforms to the provisions of the Declaration of Helsinki.
: This article does not contain any studies with human or animal subjects.
